Aruni Ghose: Male Breast Cancer, A Single Institutional Clinicopathological Profiling
Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, shared an article by Shubha De Sarkar, et al. on LinkedIn:
“Hot Off the Press!
Thanks to the International Institute of Anticancer Research.
Professor Stergios Boussios and I collaborated with Dr. Soirindhri Banerjee and Dr. Shubha De Sarkar to help draft a Single Centre Real-World Clinicopathological Epidemiological Experience on a growing entity—Male Breast Cancer—from the Institute of Post Graduate Medical Education & Research SSKM Hospital.
Compared to existing literature, this Indian cohort had a significantly higher proportion of triple-negative breast cancer (TNBC). The most common presentation was at Stage 3, between ages 41 to 60, implying a younger cohort.
My association with the UKI Global Cancer Network and Cancer Health Disparities – London Global Cancer Week (LGCW) taught me that Global Oncology is bidirectional and that you cannot equalize inequalities if you never knew the inequalities.”
Male Breast Cancer: A Single Institutional Clinicopathological Profiling.
Authors: Shubha De Sarkar, et al.
More posts featuring Aruni Ghose.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023